메뉴 건너뛰기




Volumn 30, Issue 3, 2010, Pages 438-446

dUTP pyrophosphatase expression correlates with a poor prognosis in hepatocellular carcinoma

Author keywords

DUTP pyrophosphatase; Hepatocellular carcinoma; Prognosis; Serial analysis of gene expression

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; FLUOROURACIL; SMALL INTERFERING RNA;

EID: 77950614784     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02177.x     Document Type: Article
Times cited : (23)

References (32)
  • 2
    • 34250020201 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
    • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-76.
    • (2007) Gastroenterology , vol.132 , pp. 2557-2576
    • El-Serag, H.B.1    Rudolph, K.L.2
  • 3
    • 33747830764 scopus 로고    scopus 로고
    • Hepatocellular carcinoma pathogenesis: from genes to environment
    • Farazi PA, Depinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006, 6:674-87.
    • (2006) Nat Rev Cancer , vol.6 , pp. 674-687
    • Farazi, P.A.1    Depinho, R.A.2
  • 4
    • 34547899931 scopus 로고    scopus 로고
    • Future of molecular profiling of human hepatocellular carcinoma
    • Roessler S, Budhu A, Wang XW. Future of molecular profiling of human hepatocellular carcinoma. Future Oncol 2007, 3:429-39.
    • (2007) Future Oncol , vol.3 , pp. 429-439
    • Roessler, S.1    Budhu, A.2    Wang, X.W.3
  • 6
    • 40849124295 scopus 로고    scopus 로고
    • Novel advancements in the management of hepatocellular carcinoma in 2008
    • Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008, 48((Suppl. 1)):S20-37.
    • (2008) J Hepatol , vol.48 , Issue.SUPPL. 1
    • Llovet, J.M.1    Bruix, J.2
  • 7
    • 0036189906 scopus 로고    scopus 로고
    • Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation
    • Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002, 235:373-82.
    • (2002) Ann Surg , vol.235 , pp. 373-382
    • Poon, R.T.1    Fan, S.T.2    Lo, C.M.3    Liu, C.L.4    Wong, J.5
  • 8
    • 0021070002 scopus 로고
    • Primary hepatocellular cancer-present results and future prospects
    • Friedman MA. Primary hepatocellular cancer-present results and future prospects. Int J Radiat Oncol Biol Phys 1983, 9:1841-50.
    • (1983) Int J Radiat Oncol Biol Phys , vol.9 , pp. 1841-1850
    • Friedman, M.A.1
  • 10
    • 36448942509 scopus 로고    scopus 로고
    • Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules
    • Nagano H, Miyamoto A, Wada H. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer 2007, 110:2493-501.
    • (2007) Cancer , vol.110 , pp. 2493-2501
    • Nagano, H.1    Miyamoto, A.2    Wada, H.3    et al4
  • 11
    • 0037315472 scopus 로고    scopus 로고
    • Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon alfa-2b for treatment of hepatocellular carcinoma
    • Patt YZ, Hassan MM, Lozano RD. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol 2003, 21:421-7.
    • (2003) J Clin Oncol , vol.21 , pp. 421-427
    • Patt, Y.Z.1    Hassan, M.M.2    Lozano, R.D.3    et al4
  • 12
    • 0031612291 scopus 로고    scopus 로고
    • Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma
    • Urabe T, Kaneko S, Matsushita E, Unoura M, Kobayashi K. Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma. Oncology 1998, 55:39-47.
    • (1998) Oncology , vol.55 , pp. 39-47
    • Urabe, T.1    Kaneko, S.2    Matsushita, E.3    Unoura, M.4    Kobayashi, K.5
  • 13
    • 33646383886 scopus 로고    scopus 로고
    • Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion
    • Obi S, Yoshida H, Toune R. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006, 106:1990-7.
    • (2006) Cancer , vol.106 , pp. 1990-1997
    • Obi, S.1    Yoshida, H.2    Toune, R.3    et al4
  • 14
    • 33751001342 scopus 로고    scopus 로고
    • Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C
    • Honda M, Yamashita T, Ueda T. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology 2006, 44:1122-38.
    • (2006) Hepatology , vol.44 , pp. 1122-1138
    • Honda, M.1    Yamashita, T.2    Ueda, T.3    et al4
  • 15
    • 46249109809 scopus 로고    scopus 로고
    • Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma
    • Nishino R, Honda M, Yamashita T. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J Hepatol 2008, 49:207-16.
    • (2008) J Hepatol , vol.49 , pp. 207-216
    • Nishino, R.1    Honda, M.2    Yamashita, T.3    et al4
  • 16
    • 4744354406 scopus 로고    scopus 로고
    • Genome-wide transcriptome mapping analysis identifies organ-specific gene expression patterns along human chromosomes
    • Yamashita T, Honda M, Takatori H. Genome-wide transcriptome mapping analysis identifies organ-specific gene expression patterns along human chromosomes. Genomics 2004, 84:867-75.
    • (2004) Genomics , vol.84 , pp. 867-875
    • Yamashita, T.1    Honda, M.2    Takatori, H.3    et al4
  • 17
    • 0034816235 scopus 로고    scopus 로고
    • Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma
    • Yamashita T, Kaneko S, Hashimoto S. Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma. Biochem Biophys Res Commun 2001, 282:647-54.
    • (2001) Biochem Biophys Res Commun , vol.282 , pp. 647-654
    • Yamashita, T.1    Kaneko, S.2    Hashimoto, S.3    et al4
  • 18
    • 58149288348 scopus 로고    scopus 로고
    • Application of serial analysis of gene expression in cancer research
    • Yamashita T, Honda M, Kaneko S. Application of serial analysis of gene expression in cancer research. Curr Pharm Biotechnol 2008, 9:375-82.
    • (2008) Curr Pharm Biotechnol , vol.9 , pp. 375-382
    • Yamashita, T.1    Honda, M.2    Kaneko, S.3
  • 19
    • 56949099962 scopus 로고    scopus 로고
    • Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma
    • Yamashita T, Honda M, Takatori H. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009, 50:100-10.
    • (2009) J Hepatol , vol.50 , pp. 100-110
    • Yamashita, T.1    Honda, M.2    Takatori, H.3    et al4
  • 23
    • 34247637323 scopus 로고    scopus 로고
    • Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes
    • Misu H, Takamura T, Matsuzawa N. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 2007, 50:268-77.
    • (2007) Diabetologia , vol.50 , pp. 268-277
    • Misu, H.1    Takamura, T.2    Matsuzawa, N.3    et al4
  • 24
    • 0038387494 scopus 로고    scopus 로고
    • 5-fluorouracil: mechanisms of action and clinical strategies
    • Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003, 3:330-8.
    • (2003) Nat Rev Cancer , vol.3 , pp. 330-338
    • Longley, D.B.1    Harkin, D.P.2    Johnston, P.G.3
  • 26
    • 0034234872 scopus 로고    scopus 로고
    • DUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer
    • Ladner RD, Lynch FJ, Groshen S. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer. Cancer Res 2000, 60:3493-503.
    • (2000) Cancer Res , vol.60 , pp. 3493-3503
    • Ladner, R.D.1    Lynch, F.J.2    Groshen, S.3    et al4
  • 27
    • 0023967987 scopus 로고
    • Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli
    • El-Hajj HH, Zhang H, Weiss B. Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli. J Bacteriol 1988, 170:1069-75.
    • (1988) J Bacteriol , vol.170 , pp. 1069-1075
    • El-Hajj, H.H.1    Zhang, H.2    Weiss, B.3
  • 28
    • 0028223117 scopus 로고
    • Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumor cells by expression of Escherichia coli deoxyuridinetriphosphatase
    • Canman CE, Radany EH, Parsels LA. Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumor cells by expression of Escherichia coli deoxyuridinetriphosphatase. Cancer Res 1994, 54:2296-8.
    • (1994) Cancer Res , vol.54 , pp. 2296-2298
    • Canman, C.E.1    Radany, E.H.2    Parsels, L.A.3    et al4
  • 29
    • 0032763166 scopus 로고    scopus 로고
    • Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours
    • Fleischmann J, Kremmer E, Muller S. Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours. Int J Cancer 1999, 84:614-7.
    • (1999) Int J Cancer , vol.84 , pp. 614-617
    • Fleischmann, J.1    Kremmer, E.2    Muller, S.3    et al4
  • 30
    • 27944443167 scopus 로고    scopus 로고
    • Immunohistochemical detection of dUTPase in intracranial tumors
    • Romeike BF, Bockeler A, Kremmer E. Immunohistochemical detection of dUTPase in intracranial tumors. Pathol Res Pract 2005, 201:727-32.
    • (2005) Pathol Res Pract , vol.201 , pp. 727-732
    • Romeike, B.F.1    Bockeler, A.2    Kremmer, E.3    et al4
  • 31
    • 4944241573 scopus 로고    scopus 로고
    • Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition
    • Koehler SE, Ladner RD. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition. Mol Pharmacol 2004, 66:620-6.
    • (2004) Mol Pharmacol , vol.66 , pp. 620-626
    • Koehler, S.E.1    Ladner, R.D.2
  • 32
    • 54049140420 scopus 로고    scopus 로고
    • Novel opportunities for thymidylate metabolism as a therapeutic target
    • Wilson PM, Fazzone W, Labonte MJ. Novel opportunities for thymidylate metabolism as a therapeutic target. Mol Cancer Ther 2008, 7:3029-37.
    • (2008) Mol Cancer Ther , vol.7 , pp. 3029-3037
    • Wilson, P.M.1    Fazzone, W.2    Labonte, M.J.3    et al4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.